Latest / US News Today | 2 Min News | The Daily News Now!
Oxford Vaccine Targets Deadly Ebola Strain | US News
A breakthrough vaccine for the deadly Bundibugyo Ebola strain is now in human trials after just eight weeks from concept to first dose—thanks to Oxford’s rapid development using COVID-19 tech. With over 600,000 doses ready and a deadly outbreak already claiming 1,000+ lives in DRC and Uganda, this could be the first weapon against this strain. WHO warns the outbreak is spreading faster than ever in a conflict-ridden region, while scientists race to deploy this and other emerging treatments before it’s too late. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.